MedPath

Galderma Group AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
$22.9B
Website
http://www.galderma.com/

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Phase 4
Completed
Conditions
Rosacea
Interventions
First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
26
Registration Number
NCT00436527
Locations
🇺🇸

Colorado Springs Research Center, Colorado Springs, Colorado, United States

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
2488
Registration Number
NCT00437216
Locations
🇺🇸

DHC Dimensional HealthCare, Inc. (Clinical Research Organization), Cedar Knolls, New Jersey, United States

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
78
Registration Number
NCT00436540
Locations
🇺🇸

Solano Clinical Research, Vallejo, California, United States

🇺🇸

Central Dermatology, PC, Saint Louis, Missouri, United States

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
122
Registration Number
NCT00437255
Locations
🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

🇺🇸

DermResearch, Inc., Austin, Texas, United States

🇺🇸

J & S Studies, Inc., Bryan, Texas, United States

and more 1 locations

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

Phase 4
Completed
Conditions
Acne
First Posted Date
2007-02-19
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
61
Registration Number
NCT00437151
Locations
🇺🇸

Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Benzoyl Peroxide Gel 2.5%
Drug: Gel Vehicle
First Posted Date
2007-01-15
Last Posted Date
2024-04-15
Lead Sponsor
Galderma R&D
Target Recruit Count
1668
Registration Number
NCT00422240
Locations
🇺🇸

Miller MD, San Antonio, Texas, United States

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2007-01-15
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
1670
Registration Number
NCT00421993
Locations
🇺🇸

Medical Affliated Research Center, Huntsville, Alabama, United States

🇺🇸

Dermatology Research of Arkansas, Little Rock, Arkansas, United States

🇺🇸

Associates in research, Inc., Fresno, California, United States

and more 58 locations

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

Phase 2
Completed
Conditions
Chronic Plaque Psoriasis
Interventions
First Posted Date
2007-01-09
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
25
Registration Number
NCT00419666
Locations
🇺🇸

Dermatology Research of Arkansas, Little Rock, Arkansas, United States

🇺🇸

Children's Hospital, Department of Pediatric and Adolescent Dermatology, San Diego, California, United States

🇺🇸

Dermatology Center For Children & Young Adults, Eagan, Minnesota, United States

and more 4 locations

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Phase 3
Completed
Conditions
Scalp Psoriasis
Interventions
First Posted Date
2006-11-17
Last Posted Date
2023-07-11
Lead Sponsor
Galderma R&D
Target Recruit Count
288
Registration Number
NCT00400725
Locations
🇨🇦

centre de Recherche Dermatologique du Québec, Quebec, Canada

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Phase 3
Completed
Conditions
Actinic Keratosis
First Posted Date
2006-03-24
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
80
Registration Number
NCT00306800
Locations
🇺🇸

Spencer Dermatology and Skin Surgery, Saint Petersburg, Florida, United States

🇺🇸

Laser and Skin Surgery Center, New York, New York, United States

🇺🇸

Dermatology Associates of Rochester, Rochester, New York, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath